Disease · MONDO_0001708
Trials16
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 1 more is not shown, since the checks do not confirm it.
1 to 16 of 16
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05314517 | A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis | Phase 2 | 107 | 2025-09-12 | Sarcoidosis, Pulmonary | NAMILUMAB | Its record names the disease | ClinicalTrials.gov |
| NCT02024555 | Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis | Phase 2 | 97 | 2020-07-09 | Sarcoidosis; Antimycobacterial Therapy | AZITHROMYCIN, ETHAMBUTOL, LEVOFLOXACIN, RIFAMPIN | Its record names the disease | ClinicalTrials.gov |
| NCT00279708 | Atorvastatin to Treat Pulmonary Sarcoidosis | Phase 2 | 55 | 2016-08-12 | Sarcoidosis, Pulmonary | ATORVASTATIN | Its record names the disease | ClinicalTrials.gov |
| NCT02265874 | Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study | Phase 1/2 | 50 | 2025-04-24 | Sarcoidosis | (+/-)NICOTINE, NICOTINE | Its record names the disease | ClinicalTrials.gov |
| NCT03793439 | Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis | Phase 1 | 5 | 2022-02-18 | Sarcoidosis, Pulmonary, Sarcoidosis Lung, Sarcoidosis | PREDNISONE, TOFACITINIB | Its record names the disease | ClinicalTrials.gov |
| NCT05247554 | Randomized Controlled Trial of Hydroxychloroquine Combined With Low-dose Corticosteroid in Pulmonary Sarcoidosis | Phase 3 | 200 | Pulmonary Sarcoidosis | HYDROXYCHLOROQUINE, PREDNISONE | Its record names the disease | ClinicalTrials.gov | |
| NCT00001877 | Treatment of Pulmonary Sarcoidosis With Pentoxifylline | Phase 2 | 100 | Pulmonary Sarcoidosis | PENTOXIFYLLINE | Its record names the disease | ClinicalTrials.gov | |
| NCT06205121 | Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis | Phase 2 | 96 | Pulmonary Sarcoidosis | 5-(4-((2S,5S)-5-(4-CHLOROBENZYL)-2-METHYLMORPHOLINO)PIPERIDIN-1-YL)-1H-1,2,4-TRIAZOL-3-AMINE | Its record names the disease | ClinicalTrials.gov | |
| NCT02200146 | Hydroxychloroquine as Steroid-Sparing Agent in Pulmonary Sarcoidosis (HySSAS). | Phase 3 | 94 | Pulmonary Sarcoidosis | HYDROXYCHLOROQUINE | Its record names the disease | ClinicalTrials.gov | |
| NCT00701207 | Study of Nicotine Patches in Patients With Sarcoidosis | Early phase 1 | 64 | Pulmonary Sarcoidosis | (+/-)NICOTINE, NICOTINE | Its record names the disease | ClinicalTrials.gov | |
| NCT00926627 | Safety and Efficacy Study of Bosentan in Progressive Pulmonary Sarcoidosis | Phase 2 | 32 | Sarcoidosis, Pulmonary Hypertension | BOSENTAN | Its record names the disease | ClinicalTrials.gov | |
| NCT04020380 | Azithromycin a Treatment for Pulmonary Sarcoidosis | Phase 2 | 21 | Sarcoidosis, Pulmonary | AZITHROMYCIN | Its record names the disease | ClinicalTrials.gov | |
| NCT00262132 | Mycophenolate for Pulmonary Sarcoidosis | Phase 3 | 20 | Pulmonary Sarcoidosis | MYCOPHENOLIC ACID | Its record names the disease | ClinicalTrials.gov | |
| NCT01440192 | Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Stage II or III Pulmonary Sarcoidosis | Phase 1 | 4 | Stage 2 Pulmonary Sarcoidosis, Stage 3 Pulmonary Sarcoidosis | CENPLACEL-L | Its record names the disease | ClinicalTrials.gov | |
| NCT05910554 | Investigation of the Efficacy of Metformin Therapy on Pulmonary Sarcoidosis | Phase 2 | 0 | Sarcoidosis, Pulmonary | METFORMIN | Its record names the disease | ClinicalTrials.gov | |
| NCT00000596 | Diffuse Fibrotic Lung Disease | Phase 2 | Lung Diseases, Pulmonary Fibrosis, Sarcoidosis | CYCLOPHOSPHAMIDE, DAPSONE, METHYLPREDNISOLONE, PREDNISONE | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0001708/trials